Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/08/2000CA2353108A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2352971A1 Crystalline salts of a carbapenem antibiotic
06/08/2000CA2352878A1 Antitumor dibenzofluorene derivatives
06/08/2000CA2352789A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352612A1 Pharmaceuticals
06/08/2000CA2352562A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352525A1 Agent protective against hepatopathy
06/08/2000CA2352512A1 Lak activity enhancers derived from extract of lentinus endodes mycelium and lak activity-enhancers formulations containing the extract
06/08/2000CA2352491A1 Peptides carrying substances across the blood brain barrier
06/08/2000CA2352459A1 .gamma..delta.t cell immunoactivity enhancers containing extract of lentinus edodes mycelium
06/08/2000CA2352387A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000CA2352205A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses
06/08/2000CA2352199A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
06/08/2000CA2352045A1 Substituted benzo[de]isoquinoline-1,3-diones
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2351062A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/08/2000CA2350635A1 Therapeutic product and its use
06/08/2000CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family
06/08/2000CA2350069A1 Methods to reduce variance in treatment studies using genotyping
06/08/2000CA2349402A1 A new pharmaceutical composition
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000CA2319646A1 Topiramate and related derivatives for treating schizophrenia
06/07/2000EP1006189A2 Method for the fermentative production of D-pantothenic acid using coryneform bacteria
06/07/2000EP1006126A2 Osteogenic peptides
06/07/2000EP1006115A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
06/07/2000EP1006113A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
06/07/2000EP1006110A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005868A1 Use of alpha interferon and ribavirin in the manufacture of a medicament for combination therapy for chronic hepatitis C infection
06/07/2000EP1005865A1 A anti-allergy anti-inflammatory composition comprising nimesulide and cetirizine
06/07/2000EP1005864A1 Antioxidant free stable pharmaceutical compositions containing thienopyridine derivatives
06/07/2000EP1005863A1 Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
06/07/2000EP1005862A1 Anti-chlamydia agents
06/07/2000EP1005861A1 Remedies for frequent urination and urinary incontinence
06/07/2000EP1005860A1 Non-chlorofluorocarbon aerosol formulations
06/07/2000EP1005859A1 Method for producing dispersible sterol and stanol compounds
06/07/2000EP1005855A1 Dimer alpha-alkyl-styrene derivatives as photostable UV-filters for cometical or pharmaceutical compositions
06/07/2000EP1005851A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol
06/07/2000EP1005589A1 Resin-impregnated belt having a texturized outer surface for application on papermaking machines
06/07/2000EP1005493A1 Antiviral protease inhibitors
06/07/2000EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005471A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
06/07/2000EP1005470A1 Oxindolylquinazoline derivatives as angiogenesis inhibitors
06/07/2000EP1005469A1 Oxazolidinone derivatives and their use as antibacterial agents
06/07/2000EP1005468A1 Antibiotic oxazolidinone derivatives
06/07/2000EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use
06/07/2000EP1005463A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
06/07/2000EP1005460A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
06/07/2000EP1005459A1 Substituted isoquinolines as anticonvulsivants
06/07/2000EP1005458A1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
06/07/2000EP1005454A1 2-acylaminopropanamines as tachykinin receptor antagonists
06/07/2000EP1005453A1 Substituted benzene compounds as antiproliferative and cholesterol lowering agents
06/07/2000EP1005449A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
06/07/2000EP1005446A1 N-aroylphenylalanine derivatives
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005375A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
06/07/2000EP1005374A1 Microparticles for delivery of nucleic acid
06/07/2000EP1005369A2 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/07/2000EP1005367A2 Vaccines containing bordetella pertussis antigen
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005350A1 Composition and method of treating cancer with tannic acid and tannin complexes
06/07/2000EP1005348A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
06/07/2000EP1005347A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
06/07/2000EP1005346A2 Solutions containing azasteroids
06/07/2000EP1005345A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
06/07/2000EP1005344A1 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid x receptor selective agonists
06/07/2000EP1005343A1 Use of csaid?tm compounds as inhibitors of angiogenesis
06/07/2000EP1005342A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000EP1005340A1 Retinoid antagonists for prevention of surgical adhesions
06/07/2000EP1005339A1 Carotenoid formulation
06/07/2000EP1005338A1 Substituted aurone derivatives
06/07/2000EP1005337A1 Pharmacologic drug combination in vagal-induced asystole
06/07/2000EP1005336A1 Improved methods and compositions for treating male erectile dysfunction
06/07/2000EP1005335A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
06/07/2000EP1005334A1 Neuroprotective compounds and uses thereof
06/07/2000EP1005333A1 Methods and compositions for preventing and treating chronological aging in human skin
06/07/2000EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein
06/07/2000EP1005329A1 Rapidly disintegrating methylcellulose tablets
06/07/2000EP1005328A1 Composition comprising finely divided, crystalline particles of budesonide
06/07/2000EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses
06/07/2000EP1005275A1 Inhibitor and preservative formulation
06/07/2000EP1005274A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
06/07/2000EP1005267A1 Phototherapy based method for treating pathogens and composition for effecting same
06/07/2000EP0934062A4 Antioxidant activity of 3-dehydroshikimates
06/07/2000EP0910561A4 Inhibitors of oleamide hydrolase
06/07/2000EP0855909A4 Radiosensitizing taxanes and their pharmaceutical preparations
1 ... 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 ... 7860